http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S61246124-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f20a156a8d88a4b4f24f7573f878a4e3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 1985-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cec096c7202ab7737c4f72e7bbd40f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c09c65c3d59e35b9a968f88dd6ba30fc
publicationDate 1986-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S61246124-A
titleOfInvention Carcinostatic agent
abstract PURPOSE: To provide a carcinostatic agent containing 5,7,4'-trihydroxyisoflavone as an active component and having tumor cell proliferation inhibiting activity and DNA-synthesis inhibiting activity. n CONSTITUTION: The objective agent contains 5,7,4'-trihydroxyisoflavone (general name: genistein) as an active component. Genistein is a compound separated from a certain kind of clover (Trifolium subterraneum L.) and is known to have week estrogen activity. It has been found newly that the compound is effective to inhibit the proliferation of tumor cell, the synthesis of DNA and the activity of tyrosine-specific phosphorylase. Coupled with the low acute toxicity, the compound is useful as a carcinostatic agent for the remedy of human and animal cancer, the remedy for diseases caused by the metastasis of cancer and the prevention of relapse of cancer. It is applied at a rate of usually 200W1,000mg daily in 1W4 divided doses. n COPYRIGHT: (C)1986,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7202273-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7045155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9848790-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07506822-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6599536-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5587459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7488494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1477178-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1927352-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6146668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6987098-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6642212-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6340703-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6497906-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6649648-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5911995-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6562380-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7312344-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7033621-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE40792-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1927352-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0656786-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6004558-A
priorityDate 1985-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281377
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490899
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408986

Total number of triples: 47.